Lifelong mental stimulation may prevent dementia, despite brain changes
By
Alicia Lasek
Jul 15, 2019
A lifetime of cognitively challenging activity is tied to lower dementia risk, even in people whose brains show signs of Alzheimer’s disease.
Medicare’s plan to cover Alzheimer’s drugs hinges on patient data registries
By
Alicia Lasek
Jun 02, 2023
Medicare Part B will cover Alzheimer’s drugs with traditional FDA approval, CMS announced Thursday. Prescribing clinicians must participate in a patient data registry.
CMS to weigh national Medicare coverage for Aduhelm, other Alzheimer’s drugs
By
Alicia Lasek
Jul 14, 2021
The agency is considering whether to establish a national coverage policy for monoclonal antibody drugs that treat Alzheimer’s disease, including the newly approved drug aducanumab (Aduhelm).
‘Awakenings’ in advanced dementia patients inspire search for a cause
By
Alicia Lasek
Aug 07, 2019
Scientists have begun a search for the cause of a phenomena where people with late-stage Alzheimer’s disease are very lucid near the end of life.
Initiative expands veteran participation in dementia research
By
Foster Stubbs
Feb 20, 2024
A National Institute on Aging (NIA) and Department of Veteran Affairs (VA) initiative helped to recruit more veterans for Alzheimer’s research. The program, INviting Veterans InTo Enrollment in Alzheimer’s...
Sweltering heat problematic for people with dementia
By
Kristen Fischer
Jul 13, 2023
Scorching temperatures — think triple digits — are tough for all of us, but heat can be really dangerous for a person with dementia or Alzheimer’s disease. That’s why knowing what to do — and...
Community burden of dementia symptoms mirrors that of nursing homes, caregiver survey finds
By
Alicia Lasek (f3)
Apr 29, 2022
Frequent, unsubtle symptoms have a big impact on patient quality of life, but are often unreported in primary care, investigators report.
FDA grants full approval of Alzheimer’s drug Leqembi
By
Liza Berger
Jul 07, 2023
The Food and Drug Administration (FDA) late Thursday granted full approval of the early Alzheimer’s drug Leqembi (lecanemab), opening up long-awaited broad Medicare coverage of the medication shown to...
Deep sleep may buffer against memory loss in those with Alzheimer’s brain changes: study
By
Alicia Lasek
May 05, 2023
Deep sleep may help build cognitive reserve, increasing resilience against the effects of beta-amyloid brain changes, investigators report.
Hypertension drug increases blood flow to brain regions affected by Alzheimer’s
By
Alicia Lasek
Jun 17, 2019
A hypertension drug can increase blood flow to key regions of the brain in people with Alzheimer’s Disease.